In the present study, we identified that CD34+/CD38− CML cells harboring the Bcr-Abl fusion gene, were enriched with Oct4, Sox2 and CD133 (Figure 1). This evidence concerns the gene PROM1 and chronic myelogenous leukemia, BCR-ABL1 positive.